The MH policy for pre-procedural medication management in fasting patients with diabetes was also established and involved omitting morning dose of oral hypoglycemics, short-acting, and pre-mixed insulin on the day of the procedure when fasting from midnight. This evidence concerns the gene INS and diabetes mellitus.